Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Clinical trial NCT04057573 · COMPLETED

Trial details

NCT number: NCT04057573
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-segmental Vitiligo

Start date: 2019-10-03
Primary completion: 2021-03-15
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.